Publications

EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis – Study design and patient demographics

Elborn et al. Contemporary Clinical Trials (2018)

Correlated Changes in Inflammation Biomarkers from a Phase 1 Study of Acebilustat in Adult Cystic Fibrosis Patients

Elborn et al. 40th European Cystic Fibrosis Conference (2017)

Phase 1 Studies of Acebilustat: Pharmacokinetics, Pharmacodynamics, Food Effect, and CYP3A Induction

Elborn et al. Clinical and Translational Science (2017)

Phase 1 Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis

Elborn et al. Clinical and Translational Science (2017)